about
The effect of zinc oxide nanoparticles on mouse spermatogenesisSmall solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapyPotential for layered double hydroxides-based, innovative drug delivery systemsIn vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test.Evaluation of alpha and gamma aluminum oxide nanoparticle accumulation, toxicity, and depuration in Artemia salina larvae.Layered double hydroxide-based nanocarriers for drug delivery.Hepatotoxicity and Ultra Structural Changes in Wistar Rats treated with Al2O3 NanomaterialsMetal-based nanoparticles and their toxicity assessment.In vitro antioxidant activity and in vivo antifatigue effect of layered double hydroxide nanoparticles as delivery vehicles for folic acid.Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocompositeThe in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids.Layered double hydroxide nanoparticles in gene and drug delivery.Layered double hydroxide nanoparticles promote self-renewal of mouse embryonic stem cells through the PI3K signaling pathway.Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme.Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cellsIn vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides.Synthesis of well-dispersed layered double hydroxide core@ordered mesoporous silica shell nanostructure (LDH@mSiO₂) and its application in drug delivery.Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model.Extreme Activity of Drug Nanocrystals Coated with A Layer of Non-Covalent Polymers from Self-Assembled Boric Acid.Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.Studies on fate and toxicity of nanoalumina in male albino rats: Lethality, bioaccumulation and genotoxicity.Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.Oxidative stress induced by aluminum oxide nanomaterials after acute oral treatment in Wistar rats.Aluminium oxide nanoparticles compromise spatial learning and memory performance in rats.Toxicity and biomedical imaging of layered nanohybrids in the mousePreparation of pH-Sensitive Polymers/Layered Double Hydroxide Hybrid Beads for Controlled Release of InsulinControlled release of ketorolac through nanocomposite films of hydrogel and LDH nanoparticlesBiomedical Applications of Layered Double HydroxidesAntibody-Conjugated Nanoparticles for Biomedical ApplicationsMetallic Nanoparticles: General Research Approaches to Immunological Characterization
P2860
Q28389936-841E980A-0576-4BE6-9891-01C346083C56Q28390962-57B8C7AC-361C-4CC4-BA2F-E8021193A14DQ30391504-DF744D6F-0794-45CC-9098-0C4D35EA068EQ33411683-BD0BC2E9-A45F-44ED-8980-3533564BF5B7Q33551338-CAE8A304-3D02-4C91-A46B-58DBB5A679EDQ33858677-DF3BE87D-2823-4C45-8D08-FA623598CC09Q33894435-8075DD01-F8E2-46DA-A150-29E9EC8D6D2BQ34129403-3C8CACE7-6352-404D-9FFC-7760EC2D2B7EQ34661976-A1C0366C-4625-4E7E-B3E0-6666660FDE27Q35491580-69E240C2-F97C-4574-A164-1F18938F0F12Q36835271-0598E58E-B59A-42AC-925A-3A2FAB650BE3Q36891384-871E47CD-0F74-4034-82A3-AABD15A5C93AQ37580918-E69A1267-B6FA-4A70-AA73-3EADEB856C65Q38865503-15A37B69-B9E0-44B9-B791-32CD53AB9AA2Q39294864-3DBD5DAE-CC26-4FE3-BEAC-661D94D7565FQ39305219-0879423B-CFB6-4F33-B211-2DAD84DCFDC9Q39320851-812A0861-980A-4790-B271-036A5D00D1A3Q39486616-355FBCA3-F7EC-4497-8479-6DB9BD9935BAQ39967885-373C0A71-993D-4C6E-AB52-942266A4148BQ41688660-42C75A61-82C3-4278-8FC8-5EC755269177Q41946092-BBFBB343-1A34-400C-B111-927317C03AA9Q42436184-405E22D3-97FB-4A05-BFA5-63DC7430C620Q42919601-CC8EB674-CDE1-49FC-9865-16FB9271BAF1Q46600374-8AEEC3D7-3C9C-4BC4-BD8E-AE7A99CF21CCQ46970810-56891B88-832C-4364-98E4-6C51410EC07CQ48786332-BB6C1E92-A0F8-415E-BB37-1F2085949596Q55340905-D048EF15-D3C9-4A13-B041-14C4D0B9ADA2Q57186817-EEC72BD7-7D1A-4A9D-8C7D-27217F286317Q57369146-3B69ED3B-397B-48D9-8727-98EE2786B173Q57395288-C847F569-E928-4DBF-8B70-2FE6961AC27DQ57765861-CC01345A-BB0C-4CF0-97EC-0208D4D5975EQ58648259-0E5AB19F-9298-4ED9-8276-3D463A532D6DQ59138158-841EF597-0EA5-46BD-BFB3-BD26D4A013E0
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nanobiohybrids as delivery vehicles for camptothecin.
@en
type
label
Nanobiohybrids as delivery vehicles for camptothecin.
@en
prefLabel
Nanobiohybrids as delivery vehicles for camptothecin.
@en
P2093
P1476
Nanobiohybrids as delivery vehicles for camptothecin.
@en
P2093
Emmanuel P Giannelis
Katherine M Tyner
Scott R Schiffman
P304
P356
10.1016/J.JCONREL.2003.12.027
P407
P577
2004-03-01T00:00:00Z